Integer (ITGR) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Integer Revenue Highlights

Latest Revenue (Y)

$1.72B

Latest Revenue (Q)

$467.69M

Main Segment (Y)

Cardio And Vascular

Main Geography (Y)

UNITED STATES

Integer Revenue by Period

Integer Revenue by Year

Date	Revenue	Change
2024-12-31	$1.72B	7.51%
2023-12-31	$1.60B	16.03%
2022-12-31	$1.38B	12.70%
2021-12-31	$1.22B	13.75%
2020-12-31	$1.07B	-14.68%
2019-12-31	$1.26B	3.55%
2018-12-28	$1.22B	-16.89%
2017-12-29	$1.46B	5.42%
2016-12-30	$1.39B	73.26%
2016-01-01	$800.41M	16.38%
2015-01-02	$687.79M	3.59%
2014-01-03	$663.95M	2.75%
2012-12-28	$646.18M	13.60%
2011-12-30	$568.82M	6.64%
2010-12-31	$533.42M	2.22%
2010-01-01	$521.82M	-4.54%
2009-01-02	$546.64M	71.50%
2007-12-28	$318.75M	17.56%
2006-12-29	$271.14M	12.46%
2005-12-30	$241.10M	20.48%
2004-12-31	$200.12M	-7.51%
2004-01-02	$216.37M	29.33%
2003-01-03	$167.30M	23.40%
2001-12-28	$135.57M	38.64%
2000-12-29	$97.79M	23.42%
1999-12-31	$79.23M	-

Integer generated $1.72B in revenue during NA 2024, up 7.51% compared to the previous quarter, and up 136.44% compared to the same period a year ago.

Integer Revenue by Quarter

Date	Revenue	Change
2025-09-26	$467.69M	-1.85%
2025-06-27	$476.49M	8.94%
2025-03-28	$437.39M	-2.69%
2024-12-31	$449.50M	4.19%
2024-09-27	$431.42M	-1.18%
2024-06-28	$436.57M	5.25%
2024-03-29	$414.80M	0.40%
2023-12-31	$413.15M	2.09%
2023-09-29	$404.69M	1.16%
2023-06-30	$400.04M	5.61%
2023-03-31	$378.79M	1.71%
2022-12-31	$372.42M	8.68%
2022-09-30	$342.68M	-2.11%
2022-07-01	$350.08M	12.60%
2022-04-01	$310.91M	-0.67%
2021-12-31	$313.01M	2.44%
2021-10-01	$305.57M	-2.07%
2021-07-02	$312.02M	7.42%
2021-04-02	$290.47M	8.00%
2020-12-31	$268.96M	13.99%
2020-10-02	$235.94M	-1.74%
2020-07-03	$240.12M	-26.89%
2020-04-03	$328.43M	0.86%
2019-12-31	$325.64M	7.26%
2019-09-27	$303.59M	-3.38%
2019-06-28	$314.19M	-0.15%
2019-03-29	$314.68M	3.84%
2018-12-31	$303.03M	-0.67%
2018-09-28	$305.09M	-2.98%
2018-06-29	$314.46M	-17.62%
2018-03-30	$381.75M	-2.24%
2017-12-29	$390.48M	7.48%
2017-09-29	$363.31M	0.16%
2017-06-30	$362.72M	5.01%
2017-03-31	$345.41M	-3.94%
2016-12-30	$359.59M	3.76%
2016-09-30	$346.57M	-0.52%
2016-07-01	$348.38M	4.86%
2016-04-01	$332.24M	4.62%
2016-01-01	$317.57M	116.57%
2015-10-02	$146.64M	-16.15%
2015-07-03	$174.89M	8.41%
2015-04-03	$161.32M	-4.95%
2014-12-31	$169.73M	-1.15%
2014-09-30	$171.70M	-0.22%
2014-06-30	$172.08M	-1.26%
2014-03-31	$174.28M	-1.32%
2014-01-03	$176.62M	5.30%
2013-09-27	$167.73M	-2.10%
2013-06-28	$171.33M	15.56%
2013-03-29	$148.26M	-6.86%
2012-12-28	$159.19M	-1.34%
2012-09-28	$161.34M	-3.13%
2012-06-29	$166.55M	4.68%
2012-03-30	$159.10M	12.25%
2011-12-30	$141.75M	7.61%
2011-09-30	$131.72M	-10.10%
2011-07-01	$146.52M	-1.55%
2011-04-01	$148.83M	11.81%
2010-12-31	$133.11M	4.41%
2010-10-01	$127.49M	-9.45%
2010-07-02	$140.79M	6.64%
2010-04-02	$132.03M	4.94%
2010-01-01	$125.81M	3.57%
2009-10-02	$121.47M	-9.84%
2009-07-03	$134.72M	-3.64%
2009-04-03	$139.82M	-4.63%
2009-01-02	$146.60M	7.60%
2008-09-26	$136.24M	-3.82%
2008-06-27	$141.65M	15.96%
2008-03-28	$122.15M	44.71%
2007-12-28	$84.42M	-

Integer generated $467.69M in revenue during Q3 2025, up -1.85% compared to the previous quarter, and up 107.13% compared to the same period a year ago.

Integer Revenue Breakdown

Integer Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Other Markets	$106.41M	-	-	-	-
Cardio And Vascular	$949.58M	-	-	-	-
Non-Medical Segment	-	$43.33M	$46.55M	$38.45M	$35.46M
Medical Segment	-	$1.55B	$1.33B	$1.18B	$1.04B

Integer's latest annual revenue breakdown by segment (product or service), as of Dec 24: Cardio And Vascular (89.92%), and Other Markets (10.08%).

Quarterly Revenue by Product

Product/Service	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jul 22	Apr 22	Oct 21	Jul 21	Apr 21	Oct 20	Jul 20	Apr 20
Cardio And Vascular	$277.15M	$286.86M	$258.87M	$708.57M	$241.01M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Markets	$21.39M	$17.64M	$18.18M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cardiac Rhythm Management & Neuromodulation	$169.16M	$172.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Advanced Surgical, Orthopedics, and Portable Medical	-	-	-	-	$25.31M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Medical Segment	-	-	-	-	-	$8.82M	$7.59M	$9.09M	$8.79M	$10.93M	$14.52M	$11.77M	$10.25M	$8.88M	$9.45M	$10.40M	$7.50M	$8.26M	$8.73M	$10.16M
Medical Segment	-	-	-	-	-	$427.38M	$407.21M	$404.06M	$395.90M	$389.11M	$364.27M	$330.91M	$339.83M	$302.03M	$296.12M	$301.63M	$282.96M	$227.68M	$231.38M	$318.26M

Integer's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Cardio And Vascular (59.26%), Cardiac Rhythm Management & Neuromodulation (36.17%), and Other Markets (4.57%).

Integer Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
UNITED STATES	$938.67M	$897.43M	$762.13M	$671.50M	$596.80M
Rest Of World	$516.17M	$501.25M	$423.74M	$372.44M	$321.74M
PUERTO RICO	$137.06M	$108.42M	$114.08M	$110.16M	$96.05M

Integer's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (58.97%), Rest Of World (32.42%), and PUERTO RICO (8.61%).

Integer Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ALHC	Alignment Healthcare	$2.70B	$1.02B
ITGR	Integer	$1.72B	$467.69M
LNTH	Lantheus	$1.53B	$378.05M
LIVN	LivaNova	$1.25B	$316.86M
ACAD	ACADIA Pharmaceuticals	$957.80M	$264.57M
INSP	Inspire Medical Systems	$802.80M	$217.09M
TMDX	TransMedics Group	$441.54M	$157.37M
ADMA	ADMA Biologics	$426.45M	$121.98M
MIRM	Mirum Pharmaceuticals	$336.89M	$111.58M
NVST	Envista	-	$682.10M
VKTX	Viking Therapeutics	-	-

ITGR Revenue FAQ

What is Integer’s yearly revenue?

Integer's yearly revenue for 2024 was $1.72B, representing an increase of 7.51% compared to 2023. The company's yearly revenue for 2023 was $1.6B, representing an increase of 16.03% compared to 2022. ITGR's yearly revenue for 2022 was $1.38B, representing an increase of 12.70% compared to 2021.

What is Integer’s quarterly revenue?

Integer's quarterly revenue for Q3 2025 was $467.69M, a -1.85% decrease from the previous quarter (Q2 2025), and a 8.41% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $476.49M, a 8.94% increase from the previous quarter (Q1 2025), and a 9.14% increase year-over-year (Q2 2024). ITGR's quarterly revenue for Q1 2025 was $437.39M, a -2.69% decrease from the previous quarter (Q4 2024), and a 5.45% increase year-over-year (Q1 2024).

What is Integer’s revenue growth rate?

Integer's revenue growth rate for the last 3 years (2022-2024) was 24.74%, and for the last 5 years (2020-2024) was 59.92%.

What are Integer’s revenue streams?

Integer's revenue streams in c 24 are Other Markets, and Cardio And Vascular. Other Markets generated $106.41M in revenue, accounting 10.08% of the company's total revenue Cardio And Vascular generated $949.58M in revenue, accounting 89.92% of the company's total revenue

What is Integer’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Integer was Cardio And Vascular. This segment made a revenue of $949.58M, representing 89.92% of the company's total revenue.